These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 19568816)

  • 21. Prognostic scoring in colorectal cancer liver metastases: development and validation.
    Schindl M; Wigmore SJ; Currie EJ; Laengle F; Garden OJ
    Arch Surg; 2005 Feb; 140(2):183-9. PubMed ID: 15724001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting the prognosis of anatomical liver resection for liver metastases from colorectal cancer.
    Tomizawa N; Ohwada S; Ogawa T; Tanahashi Y; Koyama T; Hamada K; Kawate S; Sunose Y
    Hepatogastroenterology; 2006; 53(67):89-93. PubMed ID: 16506383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases.
    Petrowsky H; Sturm I; Graubitz O; Kooby DA; Staib-Sebler E; Gog C; Köhne CH; Hillebrand T; Daniel PT; Fong Y; Lorenz M
    Eur J Surg Oncol; 2001 Feb; 27(1):80-7. PubMed ID: 11237496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome.
    Hamady ZZ; Malik HZ; Alwan N; Wyatt JI; Prasad KR; Toogood GJ; Lodge JP
    Eur J Surg Oncol; 2008 Feb; 34(2):180-4. PubMed ID: 17983724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis.
    Gardini A; Ercolani G; Riccobon A; Ravaioli M; Ridolfi L; Flamini E; Ridolfi R; Grazi GL; Cavallari A; Amadori D
    J Surg Oncol; 2004 Jul; 87(1):46-52. PubMed ID: 15221919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center.
    Carpizo DR; Are C; Jarnagin W; Dematteo R; Fong Y; Gönen M; Blumgart L; D'Angelica M
    Ann Surg Oncol; 2009 Aug; 16(8):2138-46. PubMed ID: 19495884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of hepatectomy in treating multiple bilobar colorectal cancer metastases.
    Tanaka K; Shimada H; Ueda M; Matsuo K; Endo I; Togo S
    Surgery; 2008 Feb; 143(2):259-70. PubMed ID: 18242343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Resection of liver metastases of colorectal cancers. Results and prognostic factors].
    Henne-Bruns D; Vogel I; Schröder S; Schreiber HW; Kremer B
    Chirurg; 1993 Apr; 64(4):283-7; discussion 288-9. PubMed ID: 8482144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma.
    Cho Y; Miyamoto M; Kato K; Fukunaga A; Shichinohe T; Kawarada Y; Hida Y; Oshikiri T; Kurokawa T; Suzuoki M; Nakakubo Y; Hiraoka K; Murakami S; Shinohara T; Itoh T; Okushiba S; Kondo S; Katoh H
    Cancer Res; 2003 Apr; 63(7):1555-9. PubMed ID: 12670904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
    Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
    J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer.
    Ito H; Are C; Gonen M; D'Angelica M; Dematteo RP; Kemeny NE; Fong Y; Blumgart LH; Jarnagin WR
    Ann Surg; 2008 Jun; 247(6):994-1002. PubMed ID: 18520227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reference values for CD4+ and CD8+ T lymphocytes with naïve or memory phenotype and their association with mortality in the elderly.
    Provinciali M; Moresi R; Donnini A; Lisa RM
    Gerontology; 2009; 55(3):314-21. PubMed ID: 19190395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Liver resection for non-colorectal, non-neuroendocrine liver metastases--is hepatic resection justified as part of the oncosurgical treatment?].
    Lehner F; Ramackers W; Bektas H; Becker T; Klempnauer J
    Zentralbl Chir; 2009 Sep; 134(5):430-6. PubMed ID: 19757343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic disseminated tumor cells in colorectal cancer UICC stage 4 patients: prognostic implications.
    Schimanski CC; Linnemann U; Galle PR; Arbogast R; Berger MR
    Int J Oncol; 2003 Sep; 23(3):791-6. PubMed ID: 12888919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of immune responses in gastric cancer patients: a possible impact of H. pylori to polarize a tumor-specific type 1 response?
    van den Engel NK; Winter H; Rüttinger D; Shau I; Schiller M; Mayer B; Moudgil T; Meimarakis G; Stolte M; Jauch KW; Fox BA; Hatz RA
    Clin Immunol; 2006 Sep; 120(3):285-96. PubMed ID: 16765089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma.
    Grabenbauer GG; Lahmer G; Distel L; Niedobitek G
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3355-60. PubMed ID: 16740757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic significance of peripheral T-lymphocyte subsets and natural killer cells in patients with colorectal cancer.
    Qiu H; Xiao-Jun W; Zhi-Wei Z; Gong C; Guo-Qiang W; Li-Yi Z; Yuan-Fang L; Rajiv-Prasad K
    Hepatogastroenterology; 2009; 56(94-95):1310-5. PubMed ID: 19950782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum arginase activity in postsurgical monitoring of patients with colorectal carcinoma.
    Porembska Z; Skwarek A; Mielczarek M; Barańczyk-Kuźma A
    Cancer; 2002 Jun; 94(11):2930-4. PubMed ID: 12115381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis.
    Dômont J; Pawlik TM; Boige V; Rose M; Weber JC; Hoff PM; Brown TD; Zorzi D; Morat L; Pignon JP; Rashid A; Jaeck D; Sabatier L; Elias D; Tursz T; Soria JC; Vauthey JN
    J Clin Oncol; 2005 May; 23(13):3086-93. PubMed ID: 15860868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.
    Pagès F; Kirilovsky A; Mlecnik B; Asslaber M; Tosolini M; Bindea G; Lagorce C; Wind P; Marliot F; Bruneval P; Zatloukal K; Trajanoski Z; Berger A; Fridman WH; Galon J
    J Clin Oncol; 2009 Dec; 27(35):5944-51. PubMed ID: 19858404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.